Melperone
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Melperone (Bunil (PT) , Buronil (AT, BE, CZ, DK, FI † , NL † , NO † , SE) , Eunerpan (DE) ) is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.
Melperone (Bunil (PT) , Buronil (AT, BE, CZ, DK, FI † , NL † , NO † , SE) , Eunerpan (DE) ) is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.
Marketing and indications
It has been tried in treatment-resistant cases of schizophrenia with some (albeit limited) success. It has also been reported effective in the treatment of L-DOPA and other forms of psychosis in Parkinson's disease (although a multicentre, double-blind, placebo-controlled study conducted in 2012 failed to support these findings ). It is also known to possess anxiolytic properties. It is marketed in the following countries: Austria Czech Republic Denmark Estonia Finland Germany Iceland Lithuania Latvia Portugal Sweden
Adverse effects
Melperone is reported to produce significantly less weight gain than clozapine and approximately as much weight gain as typical antipsychotics. It is also purported to produce around as much prolactin secretion as clozapine (which is virtually nil). It is also purported to produce sedative effects and QT interval prolongation. It is also known to produce less extrapyramidal side effects than the first-generation (typical) antipsychotic, thiothixene. It can also produce (usually relatively mild) dry mouth. Other common adverse effects include Constipation Diarrhea Nausea Vomiting Appetite loss Hypersalivation (drooling) Extrapyramidal side effects (e.g. tremor, dystonia, hypokinesis, akathisia, dyskinesias) Insomnia Agitation Headache Dizziness Fatigue Miosis Mydriasis Blurred vision Elevated liver enzymes (esp. ALT and GGTP) Rare adverse effects include Tardive dyskinesia Neuroleptic malignant syndrome Blood dyscrasias (pancytopenia, agranulocytosis, leukopenia, thrombocytopenia, etc.) Unknown frequency adverse effects include Seizures (probably rare/uncommon) Increased intraocular pressure Intrahepatic cholestasis (probably rare) Orthostatic hypotension (probably common) Arrhythmias Rash Hyperprolactinemia (which can lead to e.g. galactorrhea, gynecomastia) Weight gain Increased appetite
Pharmacology
Melperone binds to the dopamine D 2 receptor, just like all other clinically utilized antipsychotics, but it does so with a very low affinity and hence may be liable to rapidly dissociate from the D 2 receptor hence potentially giving it the profile of an atypical antipsychotic.
Synthesis
For the last step of the synthesis the sidechain 4-Chloro-4'-Fluorobutyrophenone [3874-54-2] (1) is attached to 4-Methylpiperidine (4-Pipecoline) [626-58-4] (2). PubChem Substance
Text derived from https://en.wikipedia.org/w/index.php?oldid=1329183992 under CC BY-SA 4.0; modifications have been made.